tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

TAK Stock Latest News

Takeda, Keros Therapeutics enter exclusive elritercept license agreement
The FlyTakeda, Keros Therapeutics enter exclusive elritercept license agreement
3d ago
TAK
KROS
Keros Therapeutics announces global license agreement with Takeda
PremiumThe Fly
Keros Therapeutics announces global license agreement with Takeda
3d ago
TAK
KROS
Takeda’s Strong FY2024 H1 Boosts Full-Year Outlook
PremiumCompany Announcements
Takeda’s Strong FY2024 H1 Boosts Full-Year Outlook
4d ago
6K
TAK
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
PremiumThe Fly
Hutchmed to receive milestone payment following Takeda launch of Fruzaqla
14d ago
HCM
TAK
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
29d ago
RDY
TAK
Stifel bullish on orexin, upgrades Alkermes to Buy
PremiumThe FlyStifel bullish on orexin, upgrades Alkermes to Buy
1M ago
TAK
ALKS
Takeda Pharmaceutical Announces Robust Earnings Growth
Premium
Company Announcements
Takeda Pharmaceutical Announces Robust Earnings Growth
1M ago
TAK
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
Premium
The Fly
Hutchmed to receive $20M milestone payment from Takeda for Fruzaqla sales
1M ago
HCM
TAK
Is TAK a Buy, Before Earnings?
PremiumPre-Earnings
Is TAK a Buy, Before Earnings?
1M ago
TAK
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
PremiumThe Fly
Spyre Therapeutics price target raised to $65 from $50 at Guggenheim
1M ago
TAK
SYRE
Takeda and BMC team on decarbonization across health care ecosystem
PremiumThe Fly
Takeda and BMC team on decarbonization across health care ecosystem
1M ago
TAK
Takeda, Astellas Pharma and Sumitomo Mitsui form early drug discovery JV
PremiumThe Fly
Takeda, Astellas Pharma and Sumitomo Mitsui form early drug discovery JV
2M ago
TAK
SMFG
Galecto completes strategic review, will focus on oncology, liver disease
PremiumThe FlyGalecto completes strategic review, will focus on oncology, liver disease
2M ago
TAK
GLTO
Takeda Pharmaceutical Announces Subsidiary Merger
Premium
Company Announcements
Takeda Pharmaceutical Announces Subsidiary Merger
2M ago
6K
TAK
Tempus teams withTakeda to leverage multimodal real-world datasets in oncology
Premium
The Fly
Tempus teams withTakeda to leverage multimodal real-world datasets in oncology
2M ago
TAK
TEM
Firefly Neuroscience collaborates with Takeda, Novartis
PremiumThe Fly
Firefly Neuroscience collaborates with Takeda, Novartis
3M ago
NVS
TAK
Takeda receives European Commission approval for ADZYNMA
PremiumThe Fly
Takeda receives European Commission approval for ADZYNMA
4M ago
TAK
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
PremiumThe Fly
Protagonist Therapeutics price target lowered to $43 from $45 at JMP Securities
4M ago
JNJ
TAK
AI Could Revolutionize Drug Discovery: A Look at Key Players 
PremiumMarket News
AI Could Revolutionize Drug Discovery: A Look at Key Players 
5M ago
GS
TAK
Takeda Issues $500M Senior Note Due 2034
PremiumCompany AnnouncementsTakeda Issues $500M Senior Note Due 2034
5M ago
6K
TAK
Takeda Shareholders Approve Dividends and Directors
Premium
Company Announcements
Takeda Shareholders Approve Dividends and Directors
5M ago
6K
TAK
Codexis enters asset purchase agreement with Crosswalk Therapeutics
Premium
The Fly
Codexis enters asset purchase agreement with Crosswalk Therapeutics
5M ago
TAK
CDXS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >